Company Data
Salarius Pharmaceuticals
Ticker
SLRX
Current Price
$3.9 1.3%
Market Cap
$2.0M
Price Target
Refer to Report
Volume
12.0K
52wk Range
$3.1601 - $108
Overview
Salarius Pharmaceuticals Inc is a biotechnology company developing targeted therapies to treat pediatric and other cancers, including advanced solid tumors. Its lead compound Seclidemstat is in clinical development for treating Ewing sarcoma.